Seagen has a total of 2795 patents globally, out of which 932 have been granted. Of these 2795 patents, more than 92% patents are active. The USA is where Seagen has filed the maximum number of patents, followed by Japan and Europe (EPO), it has generated an annual revenue of $1.96 billion in the year 2021. Parallelly, the USA seems to be the main focused R&D centre of Seagen.
Seagen Inc, formerly Seattle Genetics, was founded in the year 1997 by Clay B Siegall. The business is an American biotechnology firm with a focus on antibody-based cancer medicines. As of May 2023, Seagen has a market cap of $37.34 Billion.
Do read about some of the most popular patents of Seagen which have been covered by us in this article and also you can find Seagen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Seagen patent portfolio.
How many patents does the founder and the CEO of Seagen have?
The founder & CEO, Clay B Siegall, has 37 patents.
How many patents does Seagen have?
Seagen has a total of 2795 patents globally. These patents belong to 342 unique patent families. Out of 2795 patents, 2597 patents are active.
How Many Patents did Seagen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Seagen Applications Filed | Seagen Patents Granted |
| 2022 | 122 | 98 |
| 2021 | 166 | 108 |
| 2020 | 284 | 77 |
| 2019 | 202 | 88 |
| 2018 | 269 | 80 |
| 2017 | 211 | 81 |
| 2016 | 151 | 87 |
| 2015 | 168 | 61 |
| 2014 | 147 | 53 |
| 2013 | 157 | 32 |
| 2012 | 129 | 34 |
| 2011 | 197 | 21 |
Which Seagen Drug Patents are Expiring in the Next 10 Years?
The patent no. US11207324B2 which is expiring in Apr, 2038, describing treating HER2 positive cancers, including metastatic ones, involves combining an anti-HER2 antibody with tucatinib and a chemotherapy drug. This combination is used to effectively treat the cancer.
Given below is the list of few drugs patented by Seagen accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.
| Drug Name | Patent Number | Patent Title | Patent Expiration |
| Tukysa | US11207324B2 | Treatment Of HER2 Positive Cancers | Apr, 2038 |
Interested in knowing about Seagen’s Drug Patents Expiring in the next 10 years?
How many Seagen patents are Alive/Dead?
How Many Patents did Seagen File in Different Countries?
Countries in which Seagen Filed Patents
| Country | Patents |
| United States Of America | 371 |
| Japan | 222 |
| Europe | 199 |
| Australia | 177 |
| Hong Kong (S.A.R.) | 161 |
| Canada | 156 |
| Israel | 125 |
| Mexico | 119 |
| China | 115 |
| Singapore | 102 |
| Taiwan | 86 |
| Korea (South) | 79 |
| Brazil | 73 |
| New Zealand | 73 |
| India | 73 |
| South Africa | 66 |
| Spain | 56 |
| Eurasia | 39 |
| Africa | 38 |
| Denmark | 33 |
| Germany | 32 |
| Argentina | 27 |
| Poland | 24 |
| Portugal | 20 |
| Norway | 19 |
| Slovenia | 18 |
| Hungary | 14 |
| Austria | 11 |
| Russia | 9 |
| Cyprus | 8 |
Where are Research Centres of Seagen Patents Located?
10 Best Seagen Patents
US7498298B2 is the most popular patent in the Seagen portfolio. It has received 1863 citations so far from companies like Cornell Research Foundation, Genentech, and Abbott Biotherapeutics Corp..
Below is the list of 10 most cited patents of Seagen:
| Publication Number | Citation Count |
| US7498298B2 | 1863 |
| US6884869B2 | 678 |
| US7659241B2 | 636 |
| US7375078B2 | 480 |
| US20040018194A1 | 449 |
| WO2011130613A1 | 437 |
| US20030083263A1 | 430 |
| WO2011130616A1 | 420 |
| US20080305044A1 | 313 |
| WO2007008848A2 | 286 |